Form 4: Inari Medical CFO Kevin T. Strange Reports Acquisition of Shares and RSU Grant

Chief Financial Officer of Inari Medical, Kevin T. Strange, reports the acquisition of common stock through an employee stock purchase plan and the grant of restricted stock units.

Summary

• Kevin T. Strange, the CFO of Inari Medical, filed a Form 4 detailing changes in beneficial ownership.
• On February 4, 2025, Strange acquired 21,102 restricted stock units (RSUs) with a vesting commencement date of January 1, 2025.
• 1/16th of the RSUs will vest quarterly, contingent upon continued service.
• Strange also acquired 82 shares of common stock on January 31, 2025, through the company's Employee Stock Purchase Plan.
• Following these transactions, Strange beneficially owns 67,502 shares of Inari Medical stock.

Sentiment

Score: 7

Explanation: The sentiment is neutral to positive. The CFO is increasing their stake in the company, which is generally a good sign. The filing itself is routine.

Positives

• The acquisition of shares through the Employee Stock Purchase Plan demonstrates Strange's investment in the company's future.
• The RSU grant aligns Strange's interests with the long-term performance of Inari Medical.

Future Outlook

The vesting schedule of the RSUs suggests a continued commitment from the CFO to the company's performance over the coming years.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. This filing indicates the CFO's ongoing investment in the company.

Stakeholder Impact

• Shareholders may view the CFO's increased stake as a positive signal.
• Employees participating in the Employee Stock Purchase Plan also benefit from company growth.

Key Dates

Keywords

Form 4, Inari Medical, Kevin Strange, CFO, Beneficial Ownership, Restricted Stock Units, Employee Stock Purchase Plan, NARI